Nathan C. Lo

5.8k total citations · 1 hit paper
76 papers, 2.3k citations indexed

About

Nathan C. Lo is a scholar working on Infectious Diseases, Parasitology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Nathan C. Lo has authored 76 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 25 papers in Parasitology and 15 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Nathan C. Lo's work include Parasites and Host Interactions (20 papers), Global Maternal and Child Health (15 papers) and COVID-19 epidemiological studies (13 papers). Nathan C. Lo is often cited by papers focused on Parasites and Host Interactions (20 papers), Global Maternal and Child Health (15 papers) and COVID-19 epidemiological studies (13 papers). Nathan C. Lo collaborates with scholars based in United States, Switzerland and Canada. Nathan C. Lo's co-authors include Peter J. Hotez, Jason R. Andrews, Eran Bendavid, Jean T. Coulibaly, Isaac I. Bogoch, Tesfaldet T. Michael, Emmanouil S. Brilakis, Shuaib Abdullah, Vishal Patel and Mohammed Alomar and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Nathan C. Lo

68 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave

2023 133 citations Sophia T. Tan, Ada Kwan et al. profile →

Peers

Countries citing papers authored by Nathan C. Lo

Since Specialization

Citations

This map shows the geographic impact of Nathan C. Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan C. Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan C. Lo more than expected).

Fields of papers citing papers by Nathan C. Lo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan C. Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan C. Lo. The network helps show where Nathan C. Lo may publish in the future.

Co-authorship network of co-authors of Nathan C. Lo

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan C. Lo. A scholar is included among the top collaborators of Nathan C. Lo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan C. Lo. Nathan C. Lo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Strength and durability of indirect protection against SARS-CoV-2 infection through vaccine and infection-acquired immunity 2025 ·Nature Communications ·Sophia T. Tan, Isabel Rodríguez-Barraquer, Ada Kwan, Seth Blumberg, (unknown), (unknown), (unknown), Joseph A. Lewnard, David Sears, Nathan C. Lo	2
2	Afucosylation of anti-dengue IgG is associated with enhanced susceptibility to dengue virus infection postvaccination 2025 ·Science Translational Medicine ·Usama Ashraf, Saborni Chakraborty, (unknown), Nathan C. Lo, Maria Theresa Alera, (unknown), (unknown), Nelson L. Michael, Alan L. Rothman, Taia T. Wang	1
3	Modeling the Health Impact of Discontinuing COVID-19 Vaccination During Pregnancy in the US 2025 ·JAMA Pediatrics ·Nathan C. Lo, Yvonne Maldonado, (unknown), Peter J. Hotez, Mathew V. Kiang	0
4	Cost-effectiveness and public health impact of typhoid conjugate vaccine introduction strategies in Bangladesh 2024 ·Vaccine ·(unknown), Yogesh Hooda, (unknown), Nathan C. Lo, Theresa Ryckman, Arif Mohammad Tanmoy, (unknown), Jessica C. Seidman, Denise O. Garrett, Samir K. Saha, Jeremy D. Goldhaber‐Fiebert, Senjuti Saha, Jason R. Andrews	1
5	The evolution of intramitochondriality in Midichloria bacteria 2023 ·Environmental Microbiology ·(unknown), Gherard Batisti Biffignandi, Michele Castelli, Emanuela Olivieri, Emanuela Clementi, Francesco Comandatore, Laura Rinaldi, M. N. Opara, Olivier Plantard, Ana M. Palomar, Valérie Noël, (unknown), Nathan C. Lo, Benjamin L. Makepeace, Olivier Duron, Aaron R. Jex, Lionel Guy, Davide Sassera	5
6	Predicting the Public Health Impact of Bivalent Vaccines and Nirmatrelvir-Ritonavir Against Coronavirus Disease 2019 2023 ·Open Forum Infectious Diseases ·(unknown), Sophia T. Tan, Tomás M. León, Seema Jain, Robert Schechter, Nathan C. Lo	0
7	Geographic Pattern of Typhoid Fever in India: A Model-Based Estimate of Cohort and Surveillance Data 2021 ·The Journal of Infectious Diseases ·(unknown), Arun S Karthikeyan, Karthikeyan Ramanujam, (unknown), (unknown), (unknown), Theresa Ryckman, Venkata Raghava Mohan, Gagandeep Kang, Jacob John, Jason R. Andrews, Nathan C. Lo	19
8	Comparison of Strategies for Typhoid Conjugate Vaccine Introduction in India: A Cost-Effectiveness Modeling Study 2021 ·The Journal of Infectious Diseases ·Theresa Ryckman, Arun S Karthikeyan, (unknown), (unknown), Gagandeep Kang, Jeremy D. Goldhaber‐Fiebert, Jacob John, Nathan C. Lo, Jason R. Andrews	11
9	Frequency of Routine Testing for Coronavirus Disease 2019 (COVID-19) in High-risk Healthcare Environments to Reduce Outbreaks 2020 ·Clinical Infectious Diseases ·Elizabeth T. Chin, Benjamin Q. Huynh, Lloyd A. C. Chapman, Matthew Murrill, Sanjay Basu, Nathan C. Lo	61
10	Angels in disguise: sympatric hybridization in the marine angelfishes is widespread and occurs between deeply divergent lineages 2020 ·Proceedings of the Royal Society B Biological Sciences ·(unknown), J. Hobbs, (unknown), Joseph D. DiBattista, Simon Y. W. Ho, Nathan C. Lo	20
11	The 2016 California policy to eliminate nonmedical vaccine exemptions and changes in vaccine coverage: An empirical policy analysis 2019 ·PLoS Medicine ·(unknown), Hannah Karpel, Kristin L. Sainani, Yvonne Maldonado, Peter J. Hotez, Eran Bendavid, Nathan C. Lo	25
12	Extensive Diversity of RNA Viruses in Australian Ticks 2018 ·Journal of Virology ·Erin Harvey, Karrie Rose, John‐Sebastian Eden, Nathan C. Lo, (unknown), Mǎng Shī, Stephen L. Doggett, Edward C. Holmes	100
13	Invasive Pomacea snails as important intermediate hosts of Angiostrongylus cantonensis in Laos, Cambodia and Vietnam: Implications for outbreaks of eosinophilic meningitis 2018 ·Acta Tropica ·Shan Lv, Yun-Hai Guo, Hung Manh Nguyen, Sinuon Muth, Somphou Sayasone, Nathan C. Lo, Xiao‐Nong Zhou, Jason R. Andrews	29
14	Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance 2018 ·The Lancet Infectious Diseases ·Jason R. Andrews, Stephen Baker, Florian Marks, Marcella Alsan, Denise O. Garrett, Bruce G. Gellin, Samir K. Saha, Farah Naz Qamar, Mohammad Tahir Yousafzai, Isaac I. Bogoch, Marina Antillón, Virginia E. Pitzer, Jong‐Hoon Kim, Jacob John, Jillian Gauld, Vittal Mogasale, Edward T. Ryan, Stephen P. Luby, Nathan C. Lo	53
15	Mobile-phone and handheld microscopy for neglected tropical diseases 2017 ·PLoS neglected tropical diseases ·(unknown), Jean T. Coulibaly, Jennifer Keiser, Jürg Utzinger, Nathan C. Lo, (unknown), Jason R. Andrews, Isaac I. Bogoch	19
16	Assessment of global guidelines for preventive chemotherapy against schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study 2016 ·The Lancet Infectious Diseases ·Nathan C. Lo, Ying‐Si Lai, Dimitrios-Alexios Karagiannis-Voules, Isaac I. Bogoch, Jean T. Coulibaly, Eran Bendavid, Jürg Utzinger, Penelope Vounatsou, Jason R. Andrews	51
17	Are urban bandicoots solely to blame for tick concerns? 2015 ·Australian Zoologist ·(unknown), (unknown), Nathan C. Lo, Dieter F. Hochuli, Peter B. Banks	6
18	Comparison of community-wide, integrated mass drug administration strategies for schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study 2015 ·The Lancet Global Health ·Nathan C. Lo, Isaac I. Bogoch, Brian G. Blackburn, Giovanna Raso, Eliézer K. N’Goran, Jean T. Coulibaly, Sören L. Becker, Howard Abrams, Jürg Utzinger, Jason R. Andrews	79
19	Perioperative Complications After Noncardiac Surgery in Patients With Insertion of Second-Generation Drug-Eluting Stents 2014 ·The American Journal of Cardiology ·Nathan C. Lo, Anna Kotsia, George Christopoulos, Michele Roesle, Bavana V. Rangan, (unknown), (unknown), Subhash Banerjee, Emmanouil S. Brilakis	4
20	Strategies for last mile implementation of global health technologies 2014 ·The Lancet Global Health ·Tiffany E. Chao, Nathan C. Lo, Gita N. Mody, Sidhartha R. Sinha	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact